Skip to content
PatientMatchFind trials

Screener

Eligibility screening

LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes

Sponsored by Lixte Biotechnology Holdings, Inc.Study detailsClinicalTrials.gov

1 US site in FL

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.